Effects of oral administration of Bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 2, 2007, Pages 252-257

  Wang, Chongxin ^a   Shoji, Hiromichi ^a   Sato, Hiroaki ^a   Nagata, Satoru ^a   Ohtsuka, Yoshikazu ^a   Shimizu, Toshiaki ^a   Yamashiro, Yuichiro ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bifidobacterium breve; High performance liquid chromatography; Low birth weight infants; Necrotizing enterocolitis; Short chain fatty acid

Indexed keywords

ACETIC ACID; BUTYRIC ACID; LACTIC ACID; M 16V; PROBIOTIC AGENT; PROPIONIC ACID; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ARTICLE; BIFIDOBACTERIUM BREVE; CONTROLLED STUDY; DRUG EFFECT; FECES ANALYSIS; FECES LEVEL; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; BIFIDOBACTERIUM; BUTYRIC ACID; DIETARY SUPPLEMENTS; FATTY ACIDS, VOLATILE; FECES; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LACTIC ACID;

BIFIDOBACTERIUM BREVE;

EID: 33846645460     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000252184.89922.5f     Document Type: Article

References (28)

1. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6.
2. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4.
3. Gewolb IH, Schwalbe RS, Taciak VL, et al. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999;80:F167-73.
4. Sakata H, Yoshioka H, Fujita K. Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur J Pediatr 1985;144:186-90.
5. Schwiertz A, Gruhl B, Lobnitz M, et al. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 2003;54:393-9.
6. Li Y, Shimizu T, Hosaka A, et al. Effect of Bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatr Int 2004;46:509-15.
7. Cummings JH, Macfarlane GT. The control and consequence of the bacterial fermentation in human colon. J Appl Bacteriol 1991;70:443-59.
8. Macfarlane GT, Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 1997;222:3-9.
9. Cummings JH. Short chain fatty acids in the human colon. Gut 1981;22:763-79.
10. Clark DA, Miller MJS. Intraluminal pathogenesis of necrotizing enterocolitis. J Pediatr 1990;117:564-7.
11. Szylit O, Maurage C, Gasqui P, et al. Fecal short-chain fatty acids predict digestive disorders in premature infants. J Parent Enter Nutr 1998;22:136-41.
12. Lin J. Too many short chain fatty acids cause neonatal necrotizing enterocolitis. Med Hypotheses 2004;62:291-3.
13. Lin J, Nafday SM, Chauvin SN, et al. Variable effects of short chain fatty acids and lactic acid in inducing intestinal mucosal injury in newborn rats. J Pediatr Gastroenterol Nutr 2002;35:545-50.
14. Rasmussen HS, Holtug K, Ynggard C, et al. Faecal concentrations and production rates of short chain fatty acids in normal neonates. Acta Paediatr Scand 1988;77:365-8.
15. Midtvedt AC, Carlstedt DB, Norin KE, et al. Development of five metabolic activities associated with the intestinal microflora of healthy infants. J Pediatr Gastroenterol Nutr 1988;7:559-67.
16. Siigur U, Ormisson A, Tamm A. Faecal short chain fatty acids in breast-fed and bottle-fed infants. Acta Paediatr 1993;82:536-8.
17. Edwards CA, Parrett AM, Balmer SE, et al. Faecal short chain fatty acids in breast-fed and formula-fed babies. Acta Paediatr 1994;83:459-62.
18. Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980;21:793-8.
19. Csordas A. Toxicology of butyrate and short chain fatty acids. In: Hill MJ (ed). Role of Gut Bacteria in Human Toxicology and Pharmacology. Taylor & Francis: London; 1995. pp. 105-27.
20. Favre A, Szylit O, Popot F, et al. Diet, length of gestation and fecal short chain fatty acid in healthy premature neonates. J Parent Enter Nutr 2002;26:51-6.
21. Waligora-Dupriet AJ, Dugay A, Auzeil N, et al. Evidence for clostridial implication in necrotizing enterocolitis through bacteria fermentation in a gnotobiotic quail model. Pediatr Res 2005;58:629-35.
22. Fusunyan RD, Ohno Y, MacDermott RP, et al. Short chain fatty acids enhance interleukin-1b induced secretion of interleukin-8 by caco-2 cells. Gastroenterology 1995;108:A726.
23. Pender SLF, Quinn JJ, Sanderson IR, et al. Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. Am J Physiol Gastrointestinal Liver Physiol 2000;279:G918-24.
24. Butel MJ, Roland N, Hibert A, et al. Clostridial pathogenicity in experimental necrotizing enterocolitics in gnotobiotic quails and protective role of bifidobacteria. J Med Microbiol 1998;47:391-9.
25. Modler HW, Mckellar RC, Yaguchi M. Bifidobacteria and bifidogenic factors. Can Inst Food Sci Technol J 1990;23:29-41.
26. Akiyama K, Hosono S, Takahashi E, et al. Effects of oral administration of Bifidobacterium breve on development of intestinal microflora in extremely premature infants. Acta Neonatol Jap 1994;30:130-7.
27. Akiyama K, Shimata Y, Ishizeki S, et al. Effects of oral administration of Bifidobacterium longum on development of intestinal microflora in extremely premature infants (comparison with Bifidobacterium breve). Acta Neonatol Jap 1994;30:257-63.
28. Kitajima H, Sumida Y, Tanaka R, et al. Early administration of Bifidobacterium breve to preterm infants: randomized controlled trial. Arch Dis Child 1997;76:F101-7.